Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This is a 24-week randomised, multi-centre phase III study to evaluate the efficacy and
safety of dapagliflozin as monotherapy in Japanese subjects with Type 2 diabetes mellitus who
have inadequate glycemic control with diet and exercise.